Difference between revisions of "Main Page Mobile"
(Created page with "='''HemOnc.org - A Free Hematology/Oncology Reference'''= Created by oncologists as a knowledge base for providers, this site contains reference notes prepared by their peers...") |
Warner-admin (talk | contribs) m (Text replacement - "http://hemonc.org" to "https://hemonc.org") |
||
(32 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
+ | {{DISPLAYTITLE:<span style="display: none"></span>}} | ||
+ | <!--Hides title of page--> | ||
='''HemOnc.org - A Free Hematology/Oncology Reference'''= | ='''HemOnc.org - A Free Hematology/Oncology Reference'''= | ||
− | + | '''<big><big>This is an obsolete page which is no longer needed since the software that runs this site now offers better built-in support for mobile/phone/tablet users. For posterity, this page will remain here for now. <br>[https://hemonc.org/w/index.php?title=Main_Page&mobileaction=toggle_view_mobile If you wish to use the mobile version of the site, click here]. | |
+ | </big></big>''' | ||
+ | <center> | ||
+ | {| class="wikitable" | ||
+ | |- | ||
+ | | <div style="background-color: #fee0d1; border: 1px solid #808000; padding: 5px; {{border-radius|16px}}" align="right"><font size="4"><b>{{#ask: [[Regimen::+]] |?Regimen |limit=10000|format=sum}} [[Tutorial#Regimens|regimens]] on HemOnc.org</b></font></div> || <div style="background-color: #deebf6; border: 1px solid #808000; padding: 5px; {{border-radius|16px}}"><font size="4"><b>{{#ask: [[Variant::+]] |?Variant |limit=10000|format=sum}} [[Tutorial#Variants|variants]] on HemOnc.org</b></font></div> | ||
+ | |} | ||
+ | </center> | ||
+ | |||
+ | <center><big>'''[[Main Page | Desktop version of the main page]]<br>[[How to add HemOnc.org to your home screen | How to add a HemOnc.org shortcut to your mobile device's home screen]]'''</big></center> | ||
+ | {| class="wikitable" style="text-align:center;" style="color:white; font-size:225%; line-height:1.05em;" | ||
+ | !colspan="2" align="center" style="background-color:#696969"| Quick links to chemotherapy regimens | ||
+ | |- | ||
− | + | |colspan="2" align="center" style="color:white; background-color:#00008B"| '''Solid tumors''' | |
− | + | |- | |
− | + | |style="height:50px" |[[Anal cancer]] | |
+ | |[[Bladder cancer]] | ||
+ | |- | ||
+ | |style="height:50px" |[[Bone sarcoma]] | ||
+ | |[[Breast cancer]] | ||
+ | |- | ||
+ | |style="height:50px" |[[Central nervous system (CNS) cancer]] | ||
+ | |[[Cervical cancer]] | ||
+ | |- | ||
+ | |style="height:50px" |[[Colon cancer]] | ||
+ | |[[Esophageal cancer]] | ||
+ | |- | ||
+ | |style="height:50px" |[[Gastric cancer]] | ||
+ | |[[Germ cell tumors]] | ||
+ | |- | ||
+ | |style="height:50px"|[[Head and neck cancer]] | ||
+ | |[[Hepatobiliary cancer]] | ||
+ | |- | ||
+ | |style="height:50px"|[[Non-small cell lung cancer | Lung cancer, non-small cell]] | ||
+ | |[[Small cell lung cancer | Lung cancer, small cell]] | ||
+ | |- | ||
+ | |style="height:50px" |[[Melanoma]] | ||
+ | |[[Malignant pleural mesothelioma]] | ||
+ | |- | ||
+ | |style="height:50px" |[[Neuroendocrine tumor]] | ||
+ | |[[Basal cell and squamous cell skin cancer | Skin, basal & squamous cancer]] | ||
+ | |- | ||
+ | |style="height:50px"|[[Ovarian cancer]] | ||
+ | |[[Pancreatic cancer]] | ||
+ | |- | ||
+ | |style="height:50px" |[[Penile cancer]] | ||
+ | |[[Prostate cancer]] | ||
+ | |- | ||
+ | |style="height:50px" |[[Rectal cancer]] | ||
+ | |[[Renal cell carcinoma]] | ||
+ | |- | ||
+ | |style="height:50px" |[[Soft tissue sarcoma]] | ||
+ | |[[Testicular cancer]] | ||
+ | |- | ||
+ | |style="height:50px" |[[Thymoma]] | ||
+ | |[[Thyroid cancer]] | ||
+ | |- | ||
+ | |style="height:50px" |[[Unknown primary]] | ||
+ | |[[Endometrial cancer]] | ||
|- | |- | ||
|colspan="2" align="center" style="background-color:#FF0D00"| '''Acute leukemias''' | |colspan="2" align="center" style="background-color:#FF0D00"| '''Acute leukemias''' | ||
Line 17: | Line 74: | ||
|colspan="2" align="center" style="background-color:#FF0D00"| '''Myeloproliferative neoplasms and myelodysplastic syndromes''' | |colspan="2" align="center" style="background-color:#FF0D00"| '''Myeloproliferative neoplasms and myelodysplastic syndromes''' | ||
|- | |- | ||
− | |style="height:50px" |[[Chronic | + | |style="height:50px" |[[Chronic myeloid leukemia | Chronic myelogenous leukemia (CML)]] |
|[[Chronic myelomonocytic leukemia | Chronic myelomonocytic leukemia (CMML)]] | |[[Chronic myelomonocytic leukemia | Chronic myelomonocytic leukemia (CMML)]] | ||
|- | |- | ||
Line 31: | Line 88: | ||
|colspan="2" align="center" style="background-color:#FF0D00"| '''Mature B-, T-, and NK-cell neoplasms''' | |colspan="2" align="center" style="background-color:#FF0D00"| '''Mature B-, T-, and NK-cell neoplasms''' | ||
|- | |- | ||
− | |style="height:50px" |[[ | + | |style="height:50px" |[[Anaplastic large cell lymphoma|Anaplastic large cell lymphoma (ALCL)]] |
− | |[[ | + | |[[Burkitt lymphoma|Burkitt lymphoma (BL) or Burkitt-like lymphoma]] |
|- | |- | ||
− | |style="height:50px" |[[ | + | |style="height:50px" |[[Chronic lymphocytic leukemia | Chronic lymphocytic leukemia (CLL/SLL)]] |
− | |[[ | + | |[[CNS lymphoma]] |
|- | |- | ||
− | |style="height:50px" |[[Hairy cell leukemia]] | + | |style="height:50px" |[[Cutaneous T-cell lymphoma|Cutaneous T-cell lymphoma (CTCL)]] |
+ | |[[Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma (DLBCL)]] | ||
+ | |- | ||
+ | |style="height:50px" |[[Extranodal NK- and T-cell lymphoma, nasal type]] | ||
+ | |[[Follicular lymphoma|Follicular lymphoma (FL)]] | ||
+ | |- | ||
+ | |style="height:50px" |[[Hairy cell leukemia|Hairy cell leukemia (HCL)]] | ||
|[[HIV-associated lymphoma]] | |[[HIV-associated lymphoma]] | ||
|- | |- | ||
− | |style="height:50px" |[[Hodgkin lymphoma]] | + | |style="height:50px" |[[Classical Hodgkin lymphoma|Hodgkin lymphoma (HL)]] |
− | |[[Hodgkin lymphoma, nodular lymphocyte-predominant]] | + | |[[Hodgkin lymphoma, nodular lymphocyte-predominant|Hodgkin lymphoma, nodular lymphocyte-predominant (NLP-HL)]] |
|- | |- | ||
− | |style="height:50px" |[[Large granular lymphocytic leukemia]] | + | |style="height:50px" |[[Large granular lymphocytic leukemia|Large granular lymphocytic (LGL) leukemia]] |
|[[Light-chain (AL) amyloidosis]] | |[[Light-chain (AL) amyloidosis]] | ||
|- | |- | ||
− | |style="height:50px" |[[Mantle cell lymphoma]] | + | |style="height:50px" |[[Mantle cell lymphoma|Mantle cell lymphoma (MCL)]] |
− | |[[Marginal zone lymphoma]] | + | |[[Marginal zone lymphoma|Marginal zone lymphoma (MZL)]] |
+ | |- | ||
+ | |style="height:50px" |[[Mediastinal gray-zone lymphoma|Mediastinal gray-zone lymphoma (MGZL)]] | ||
+ | |[[Multiple myeloma|Multiple myeloma (MM)]] | ||
+ | |- | ||
+ | |style="height:50px" |[[NK- and T-cell lymphoma]] | ||
+ | |[[Peripheral T-cell lymphoma|Peripheral T-cell Lymphoma (PTCL)]] | ||
|- | |- | ||
− | |style="height:50px" |[[ | + | |style="height:50px" |[[Primary mediastinal B-cell lymphoma|Primary mediastinal B-cell lymphoma (PMBL)]] |
− | |[[ | + | |[[Transformed lymphoma|Transformed lymphoma (TL)]] |
|- | |- | ||
|style="height:50px" |[[Transplant conditioning regimens]] | |style="height:50px" |[[Transplant conditioning regimens]] | ||
− | |[[Waldenström macroglobulinemia]] | + | |[[Waldenström macroglobulinemia|Waldenström macroglobulinemia (WM/LPL)]] |
|- | |- | ||
|colspan="2" align="center" style="background-color:#FF0D00"| '''Other hematology''' | |colspan="2" align="center" style="background-color:#FF0D00"| '''Other hematology''' | ||
|- | |- | ||
|style="height:50px" |[[Aplastic anemia]] | |style="height:50px" |[[Aplastic anemia]] | ||
− | |[[ | + | |[[Immune thrombocytopenia (ITP)]] |
|- | |- | ||
− | |style="height:50px" |[[ | + | |style="height:50px" |[[Castleman disease]] |
|[[Coagulopathies]] | |[[Coagulopathies]] | ||
|- | |- | ||
− | |style="height:50px" |[[ | + | |style="height:50px" |[[Hemophagocytic lymphohistiocytosis (HLH)]] |
− | |[[ | + | |[[Histiocytoses]] |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
− | |style="height:50px" |[[ | + | |style="height:50px" |[[Paroxysmal_nocturnal_hemoglobinuria]] |
− | |[[ | + | |[[Venous_thromboembolism]] |
|- | |- | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|} | |} | ||
+ | <br><center><big>'''[[Special:AllPages|Browse our complete index of pages]]'''</big></center> | ||
<br><inputbox> | <br><inputbox> | ||
type=create | type=create | ||
Line 119: | Line 146: | ||
break=no | break=no | ||
</inputbox> | </inputbox> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | + | Created by oncologists as a knowledge base for providers, this site contains reference notes prepared by their peers and allows people to share wisdom and insights from their own clinical experiences for the benefit of all. This shared online notebook will continue to evolve and grow to meet the needs of the community because users such as yourself are able to refine and build upon existing content. Please see the [[Main Page | desktop version of the main page]] for more information about [[Main Page | HemOnc.org]]. | |
− | + | [[Category:Obsolete pages]] |
Latest revision as of 19:32, 23 June 2024
HemOnc.org - A Free Hematology/Oncology Reference
This is an obsolete page which is no longer needed since the software that runs this site now offers better built-in support for mobile/phone/tablet users. For posterity, this page will remain here for now.
If you wish to use the mobile version of the site, click here.
4,428 regimens on HemOnc.org |
6,544 variants on HemOnc.org
|
How to add a HemOnc.org shortcut to your mobile device's home screen
Created by oncologists as a knowledge base for providers, this site contains reference notes prepared by their peers and allows people to share wisdom and insights from their own clinical experiences for the benefit of all. This shared online notebook will continue to evolve and grow to meet the needs of the community because users such as yourself are able to refine and build upon existing content. Please see the desktop version of the main page for more information about HemOnc.org.